Clinical trials
Completed Leishmaniasis, Visceral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drugs for Neglected Diseases | 8 |
| Banaras Hindu University | 7 |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 5 |
| PATH | 3 |
| Access to Advanced Health Institute (AAHI) | 2 |
| Foundation for Innovative New Diagnostics, Switzerland | 2 |
| Sichuan Huiyu Pharmaceutical Co., Ltd | 2 |
| Aurobindo Pharma Ltd | 1 |
| Bharat Serums and Vaccines Limited | 1 |
| Epicentre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leishmaniasis, Visceral | 43 |
| Leishmaniasis | 4 |
| Disease | 2 |
| Febrile Neutropenia | 2 |
| Invasive Fungal Infections | 2 |
| Malnutrition | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Brucellosis | 1 |
| Chagas Disease | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.